Cargando…
Magnitude of the Potential Screening Gap for Fabry Disease in Manitoba: A Population-Based Retrospective Cohort Study
BACKGROUND: Fabry disease is a rare disorder caused by the deficient activity of α-galactosidase A (GLA) that often leads to organ damage. Fabry disease can be treated with enzyme replacement or pharmacological therapy, but due to its rarity and nonspecific manifestations, it often goes undiagnosed....
Autores principales: | Whitlock, Reid H., Nour-Mohammadi, Mohammad, Curtis, Sarah, Komenda, Paul, Bohm, Clara, Collister, David, Tangri, Navdeep, Rigatto, Claudio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031591/ https://www.ncbi.nlm.nih.gov/pubmed/36970566 http://dx.doi.org/10.1177/20543581231162218 |
Ejemplares similares
-
Validation of the Kidney Failure Risk Equation in Manitoba
por: Whitlock, Reid H., et al.
Publicado: (2017) -
Prescription patterns of sodium and calcium polystyrene sulfonate in patients with hyperkalemia and chronic kidney disease receiving RAAS inhibitors
por: Ren, Hongru, et al.
Publicado: (2022) -
Costs of Assisted Home Dialysis: A Single-Payer Canadian Model From Manitoba
por: Bamforth, Ryan J., et al.
Publicado: (2021) -
Hyperkalemia and its Association With Mortality, Cardiovascular Events, Hospitalizations, and Intensive Care Unit Admissions in a Population-Based Retrospective Cohort
por: Hougen, Ingrid, et al.
Publicado: (2021) -
Metabolic Acidosis is Associated With Acute Kidney Injury in Patients With CKD
por: Zhu, Antonia, et al.
Publicado: (2022)